Apple Heart & Movement Study

Active, not recruiting

• Conditions: Prevention
• Interventions: Diagnostic Test: Predictors of events

• Registration Number: NCT04198194
• Lead Sponsor: Apple Inc.

Brief Summary

This study will look for factors that affect heart health and potentially cause deterioration in mobility or heart function. Participant's Apple Watch and iPhone can help researchers gain a better understanding of potential early warning signs. This can lead to new interventions and products that will help millions lead longer, healthier, and more active lives.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-11-13
• Study Start: 2019-11-14
• Study First Submitted QC: 2019-12-12
• Study First Posted: 2019-12-13
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-20
• Last Update Posted: 2025-02-21
• Primary Completion: 2025-02-28
• Study Completion: 2025-02-28

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 500000

Inclusion Criteria

• Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico);
• Live in the United States of America;
• Have an iPhone;
• Have an Apple Watch (Series 1 or later) at the time of enrollment;
• Have the Apple Research app installed on your iPhone;
• Be comfortable communicating in written and spoken English;
• Not share your iCloud account, iPhone, or Apple Watch with anyone else;
• Be willing and able to provide informed consent to participate in the study.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Participants with events	Predictors of events	Individuals who have experienced any of the listed outcomes

Primary Outcome Measures

Name	Time	Method
Number of Participants with Chronic Disease Events	quarterly (every 90 days) through study completion (up to 5 years)	Change in number of participants with incident cardiovascular disease events (including myocardial infarction, coronary revascularization, heart failure hospitalization, stroke/TIA hospitalization, atrial fibrillation, and atrial fibrillation hospitalization), fall events, and other hospitalizations, assessed by patient report.

Trial Locations

Locations (1)

Brigham and Women's Hospital; 🇺🇸 Boston, Massachusetts, United States